Poland proposes borderline product committee in reorganisation plans
This article was originally published in Clinica
Executive Summary
Poland is moving with the challenges created by technological change and looking at setting up a specific committee responsible for the scientific assessment of borderline products in the healthcare area, such as drug/device combinations. This is one of the proposals contained in a ministry of health draft document on the reorganisation of the country's medicines agency (URPL).